CA2011238A1 - Traitement pharmaceutique - Google Patents

Traitement pharmaceutique

Info

Publication number
CA2011238A1
CA2011238A1 CA2011238A CA2011238A CA2011238A1 CA 2011238 A1 CA2011238 A1 CA 2011238A1 CA 2011238 A CA2011238 A CA 2011238A CA 2011238 A CA2011238 A CA 2011238A CA 2011238 A1 CA2011238 A1 CA 2011238A1
Authority
CA
Canada
Prior art keywords
pharmaceutical treatment
treatment
hepatitis
pro
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2011238A
Other languages
English (en)
Other versions
CA2011238C (fr
Inventor
Malcolm Richard Boyd
David Sutton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10652653&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2011238(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2011238A1 publication Critical patent/CA2011238A1/fr
Application granted granted Critical
Publication of CA2011238C publication Critical patent/CA2011238C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002011238A 1989-03-03 1990-03-01 Traitement pharmaceutique Expired - Lifetime CA2011238C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8904855.7 1989-03-03
GB898904855A GB8904855D0 (en) 1989-03-03 1989-03-03 Pharmaceutical treatment

Publications (2)

Publication Number Publication Date
CA2011238A1 true CA2011238A1 (fr) 1990-09-03
CA2011238C CA2011238C (fr) 2000-03-28

Family

ID=10652653

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002011238A Expired - Lifetime CA2011238C (fr) 1989-03-03 1990-03-01 Traitement pharmaceutique

Country Status (18)

Country Link
US (1) US6136813A (fr)
EP (1) EP0388049B1 (fr)
JP (1) JP2513519B2 (fr)
KR (1) KR0143410B1 (fr)
AT (1) ATE122562T1 (fr)
AU (1) AU628137B2 (fr)
CA (1) CA2011238C (fr)
CY (1) CY1870A (fr)
DE (1) DE69019404T2 (fr)
DK (1) DK0388049T3 (fr)
ES (1) ES2072386T3 (fr)
GB (1) GB8904855D0 (fr)
HK (1) HK116795A (fr)
HU (1) HU205715B (fr)
IE (1) IE67125B1 (fr)
IL (1) IL93594A (fr)
LV (1) LV10923B (fr)
ZA (1) ZA901572B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
WO1995022330A1 (fr) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Agents antiviraux
ES2203692T3 (es) 1995-04-24 2004-04-16 Novartis International Pharmaceutical Ltd. Uso de trifosfato de (r)-penciclovir para la fabricacion de un medicamento para el tratamiento de enfermedades viricas.
WO1998023285A1 (fr) * 1996-11-29 1998-06-04 Smithkline Beecham Plc Utilisation d'une combinaison de penciclovir et d'alpha-interferon pour preparer un medicament servant a traiter l'hepatite b
US5939423A (en) * 1997-04-16 1999-08-17 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir
AUPO912997A0 (en) * 1997-09-11 1997-10-02 Commonwealth Scientific And Industrial Research Organisation Antiviral agents
US6288033B1 (en) 1998-09-25 2001-09-11 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir
IL142910A0 (en) * 1998-11-02 2002-04-21 Triangle Pharmaceuticals Inc Combination therapy to treat hepatitis b virus
EP2846788A1 (fr) 2012-05-11 2015-03-18 Akron Molecules AG Utilisation de composés pour le traitement de la douleur

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4230708A (en) * 1977-10-20 1980-10-28 Stichting Rega V.Z.W. Therapeutic application of (S) -or (RS)-9-(2, 3-dihydroxypropyl) adenine for use as antiviral agents
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
US5059604A (en) * 1982-10-14 1991-10-22 Burroughs Wellcome Co. 2-amino purine derivatives
US4649140A (en) * 1982-10-14 1987-03-10 Burroughs Wellcome Co. Purine derivatives
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
EP0182024B1 (fr) * 1984-09-20 1991-04-03 Beecham Group Plc Dérivés de purine et leur utilisation pharmaceutique
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
DE3671227D1 (de) * 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
HU196038B (en) * 1987-08-07 1988-09-28 Mta Koezponti Kemiai Kutato In Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine
SE8801729D0 (sv) * 1988-05-06 1988-05-06 Astra Ab Purine derivatives for use in therapy
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
HU901252D0 (en) 1990-05-28
ATE122562T1 (de) 1995-06-15
US6136813A (en) 2000-10-24
EP0388049A3 (fr) 1991-11-06
KR900014385A (ko) 1990-10-23
LV10923B (en) 1996-06-20
EP0388049B1 (fr) 1995-05-17
DK0388049T3 (da) 1995-06-06
ES2072386T3 (es) 1995-07-16
CA2011238C (fr) 2000-03-28
CY1870A (en) 1996-04-05
EP0388049A2 (fr) 1990-09-19
DE69019404T2 (de) 1995-10-12
HU205715B (en) 1992-06-29
ZA901572B (en) 1991-03-27
IL93594A (en) 1995-05-26
JPH02275821A (ja) 1990-11-09
IE67125B1 (en) 1996-03-06
DE69019404D1 (de) 1995-06-22
HUT53522A (en) 1990-11-28
IE900733L (en) 1990-09-03
JP2513519B2 (ja) 1996-07-03
IL93594A0 (en) 1990-12-23
AU5060090A (en) 1990-11-01
AU628137B2 (en) 1992-09-10
GB8904855D0 (en) 1989-04-12
HK116795A (en) 1995-07-21
LV10923A (lv) 1995-12-20
KR0143410B1 (ko) 1998-07-15

Similar Documents

Publication Publication Date Title
USD314780S (en) Pair of sunglasses or the like
USD306511S (en) Sports jacket
CA2044515A1 (fr) Derives d'amides cycliques
ATE131730T1 (de) Nukleosidanalogen enthaltende antiviren- zubereitungen
DK0390369T3 (da) Oralt indgivelige ibuprofenpræparater
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
AU650484B2 (en) Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof
CA2011238A1 (fr) Traitement pharmaceutique
CA2219070A1 (fr) Methodes pour prevenir le cancer du sein
CA2530543A1 (fr) Analogues de l'illudine utilises comme agents anti-tumoraux
AU7677891A (en) Inhibition of disease associated with immunodeficiency virus infection
DK627987A (da) Farmaceutiske praeparater
CA2032254A1 (fr) Derives de glycerol, mode de preparation et compositions therapeutiques en contenant
AU4688696A (en) Drugs to prevent recurrent herpes virus infections
CA2018794A1 (fr) Sels d'addition acides de cephem cristallins et procede de preparation
EP0347749A3 (fr) Dérivés de la pyrazoloacridone ayant une activité antitumorale
USD299034S (en) Sunglasses
USD309838S (en) Etagere
CA2045761A1 (fr) Monosulfate ou disulfate ws7622a; methode de preparation et utilisation
USD301563S (en) Charm or the like
USD313109S (en) Pair of trousers
CA2169695A1 (fr) Derives de substitution de benzenesulfonylurees et de thiourees; methodes de preparation et utilisation pour l'obtention de preparations pharmaceutiques et de medicaments a base de ces derives
USD326009S (en) Jacket
USD319284S (en) Wave suppressor
USD326576S (en) Table leg

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry